⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
globenewswire.com
RXRX
BOXBOX Emerges from Stealth to Redefine Men's Personal Care
prnewswire.com
RXRX
AI in Drug Discovery Market Size to Worth USD 17.56 Billion by 2031, at a CAGR of 28.1% – MarketsandMarkets™
globenewswire.com
NVDA
MSFT
RXRX
GOOG
ILMN
RLAY
Form 8-K
sec.gov
RXRX
Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
globenewswire.com
RXRX
Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
globenewswire.com
RXRX
Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone
globenewswire.com
RXRX
Global Preclinical Imaging Market - Size, Share, Trends, Opportunities, and Forecast, 2021-2031F | AI and Multimodal Systems Drive 6.27% CAGR and Drug Discovery Growth
globenewswire.com
JNJ
BRKR
RXRX
RVTY
AI in Drug Discovery Market Size, Share, Trends, and Forecast, 2026-2035 | Generative AI and Precision Medicine Drive 30.5% CAGR to USD 43.9 Billion
globenewswire.com
GOOGL
MSFT
NVDA
IBM
RXRX
ATOM
Computational Drug Discovery Market Size, Share, Trends, and Growth Forecasts, 2026-2031 Report Released; Analysts Predict Computational Drug Discovery Market to Reach USD 6.47 Billion by 2031 as AI Adoption Accelerates
globenewswire.com
NVDA
ISPC
RXRX
SRPT
CERT
AZN